Rule-out of non-ST elevation myocardial infarction by five point of care cardiac troponin assays according to the 0 h/3 h algorithm of the European Society of Cardiology
-
Durie Suh
and
Joanna Gawinecka
Abstract
Background:
Point of care (POC) assays for cardiac troponins I or T (cTnI or cTnT) may accelerate the diagnosis of patients with suspected acute coronary syndrome (ACS). However, their clinical utility according to the 0 h/3 h algorithm recommended by the European Society of Cardiology (ESC) for non-ST elevation myocardial infarction (NSTEMI) is unknown.
Methods:
Blood samples from 90 patients with suspected ACS were obtained at hospital admission and 3 h later. Concentrations of cTn were determined using five POC assays (AQT90 FLEX cTnI and cTnT; PATHFAST™ cTnI; Stratus CS 200 cTnI; and Triage MeterPro cTnI) and two guideline-acceptable high-sensitivity (hs) immunoassays.
Results:
For the diagnosis of NSTEMI (n=15), AUCs for Abbott hs-cTnI and Roche hs-cTnT were 0.86 [95% confidence interval (CI), 0.75–0.96] and 0.88 (95% CI, 0.80–0.95), respectively, at admission, and 0.96 and 0.94, respectively, 3 h later. With the 99th percentile cutoff, their sensitivities were 62% and 92%, respectively, at admission, and 77% and 100%, respectively, 3 h later. The PATHFAST™ cTnI assay showed AUCs of 0.90 (95% CI, 0.82–0.97) and 0.94 (95% CI, 0.89–1.00), respectively, and sensitivities of 67% and 75% at admission and 3 h later, respectively. The other cTn POC assays had AUCs of 0.71 (95% CI, 0.53–0.89) to 0.84 (95% CI, 0.71–0.96) and 0.86 (95% CI, 0.72–0.99) to 0.87 (95% CI, 0.75–0.99) and sensitivities of 39%–50% and 62%–77% at admission and 3 h later, respectively.
Conclusions:
PATHFAST™ cTnI assay proved itself as comparable to ESC-guideline acceptable hs-cTn assays. The lower sensitivity of the other POC assays limits their clinical utility and would require longer follow-up monitoring of patients for the safe NSTEMI rule-out.
Author contributions: All the authors have accepted responsibility for the entire content of this submitted manuscript and approved submission.
Research funding: None declared.
Employment or leadership: None declared.
Honorarium: None declared.
Competing interests: The funding organization(s) played no role in the study design; in the collection, analysis, and interpretation of data; in the writing of the report; or in the decision to submit the report for publication.
References
1. Task Force on the management of ST-segment elevation acute myocardial infarction of the European Society of Cardiology (ESC), Steg PG, James SK, Atar D, Badano LP, Blomstrom-Lundqvist C, et al. ESC Guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation. Eur Heart J 2012;33:2569–619.10.1016/j.rec.2012.10.010Search in Google Scholar
2. Roffi M, Patrono C, Collet JP, Mueller C, Valgimigli M, Andreotti F, et al. 2015 ECS guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation: task force for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation of the european society of cardiology (ECS). Eur Heart J 2016;37:267–315.10.1093/eurheartj/ehv320Search in Google Scholar PubMed
3. Thygesen K, Alpert JS, Jaffe AS, Simoons ML, Chaitman BR, White HD, et al. Third universal definition of myocardial infarction. J Am Coll Cardiol 2012;60:1581–98.10.1016/j.jacc.2012.08.001Search in Google Scholar PubMed
4. Apple FS. A new season for cardiac troponin assays: it’s time to keep a scorecard. Clin Chem 2009;55:1303–6.10.1373/clinchem.2009.128363Search in Google Scholar PubMed
5. Novis DA, Jones BA, Dale JC, Walsh MK, College of American P. Biochemical markers of myocardial injury test turnaround time: a College of American Pathologists Q-Probes study of 7020 troponin and 4368 creatine kinase-mb determinations in 159 institutions. Arch Pathol Lab Med 2004;128:158–64.10.5858/2004-128-158-BMOMITSearch in Google Scholar PubMed
6. Ryan RJ, Lindsell CJ, Hollander JE, O’Neil B, Jackson R, Schreiber D, et al. A multicenter randomized controlled trial comparing central laboratory and point-of-care cardiac marker testing strategies: the disposition impacted by serial point of care markers in acute coronary syndromes (dispo-acs) trial. Ann Emerg Med 2009;53:321–8.10.1016/j.annemergmed.2008.06.464Search in Google Scholar PubMed
7. Nilsson S, Andersson A, Janzon M, Karlsson JE, Levin LA. Cost consequences of point-of-care troponin T testing in a swedish primary health care setting. Scand J Prim Health Care 2014;32:241–7.10.3109/02813432.2014.984901Search in Google Scholar PubMed PubMed Central
8. Ezekowitz JA, Welsh RC, Weiss D, Chan M, Keeble W, Khadour F, et al. Providing rapid out of hospital acute cardiovascular treatment 4 (proact-4). J Am Heart Assoc 2015;4:e002859.10.1161/JAHA.115.002859Search in Google Scholar PubMed PubMed Central
9. Goodacre S, Bradburn M, Fitzgerald P, Cross E, Collinson P, Gray A, et al. The RATPAC (Randomised Assessment of Treatment using Panel Assay of Cardiac markers) trial: a randomised controlled trial of point-of-care cardiac markers in the emergency department. Health Technol Assess 2011;15:iii–xi.10.3310/hta15230Search in Google Scholar PubMed
10. Jaffe AS, Apple FS, Morrow DA, Lindahl B, Katus HA. Being rational about (im)precision: a statement from the biochemistry subcommittee of the joint european society of cardiology/american college of cardiology foundation/american heart association/world heart federation task force for the definition of myocardial infarction. Clin Chem 2010;56:941–3.10.1373/clinchem.2010.143958Search in Google Scholar PubMed
11. Reiter M, Twerenbold R, Reichlin T, Benz B, Haaf P, Meissner J, et al. Early diagnosis of acute myocardial infarction in patients with pre-existing coronary artery disease using more sensitive cardiac troponin assays. Eur Heart J 2012;33:988–97.10.1093/eurheartj/ehr376Search in Google Scholar PubMed
12. Cullen L, Aldous S, Than M, Greenslade JH, Tate JR, George PM, et al. Comparison of high sensitivity troponin T and I assays in the diagnosis of non-ST elevation acute myocardial infarction in emergency patients with chest pain. Clin Biochem 2014;47:321–6.10.1016/j.clinbiochem.2013.11.019Search in Google Scholar PubMed
13. Clerico A, Giannoni A, Prontera C, Giovannini S. High-sensitivity troponin: A new tool for pathophysiological investigation and clinical practice. Adv Clin Chem 2009;49:1–30.10.1016/S0065-2423(09)49001-2Search in Google Scholar
14. Hjortshoj S, Venge P, Ravkilde J. Clinical performance of a new point-of-care cardiac troponin I assay compared to three laboratory troponin assays. Clin Chim Acta 2011;412:370–5.10.1016/j.cca.2010.11.015Search in Google Scholar PubMed
15. Slagman A, von Recum J, Mockel M, Holert F, Meyer Zum Buschenfelde D, Muller C, et al. Diagnostic performance of a high-sensitive troponin T assay and a troponin T point of care assay in the clinical routine of an emergency department: a clinical cohort study. Int J Cardiol 2017;230:454–60.10.1016/j.ijcard.2016.12.085Search in Google Scholar PubMed
Supplemental Material:
The online version of this article offers supplementary material (https://doi.org/10.1515/cclm-2017-0486).
©2018 Walter de Gruyter GmbH, Berlin/Boston
Articles in the same Issue
- Frontmatter
- Editorial
- Visual assessment of sample quality: quo usque tandem?
- Reviews
- Machine learning in laboratory medicine: waiting for the flood?
- Is irisin the new player in exercise-induced adaptations or not? A 2017 update
- Opinion Paper
- Can a combination of average of normals and “real time” External Quality Assurance replace Internal Quality Control?
- Genetics and Molecular Diagnostics
- The UGT1A1*28 gene variant predicts long-term mortality in patients undergoing coronary angiography
- General Clinical Chemistry and Laboratory Medicine
- Laboratory performance of sweat conductivity for the screening of cystic fibrosis
- Making sense of a haemolysis monitoring and reporting system: a nationwide longitudinal multimethod study of 68 Australian laboratory participant organisations
- Visual assessment of hemolysis affects patient safety
- Strong impact on plasma protein profiles by precentrifugation delay but not by repeated freeze-thaw cycles, as analyzed using multiplex proximity extension assays
- Validation of the Six Sigma Z-score for the quality assessment of clinical laboratory timeliness
- Proficiency testing program for hemoglobin E, A2 and F analysis in Thailand using lyophilized hemoglobin control materials
- Application of κ free light chains in cerebrospinal fluid as a biomarker in multiple sclerosis diagnosis: development of a diagnosis algorithm
- Antiphosphatidylserine/prothrombin antibodies (aPS/PT) as potential diagnostic markers and risk predictors of venous thrombosis and obstetric complications in antiphospholipid syndrome
- An evaluation of the SENTiFIT 270 analyser for quantitation of faecal haemoglobin in the investigation of patients with suspected colorectal cancer
- Evaluation of the Aptima HBV Quant assay vs. the COBAS TaqMan HBV test using the high pure system for the quantitation of HBV DNA in plasma and serum samples
- Reference Values and Biological Variations
- Reference intervals for stone risk factors in 24-h urine among healthy adults of the Han population in China
- Cardiovascular Diseases
- Rule-out of non-ST elevation myocardial infarction by five point of care cardiac troponin assays according to the 0 h/3 h algorithm of the European Society of Cardiology
- Infectious Diseases
- Diagnostic and prognostic value of presepsin vs. established biomarkers in critically ill patients with sepsis or systemic inflammatory response syndrome
- Association of adrenal hormone metabolites and mortality over a 6-year follow-up in COPD patients with acute exacerbation
- Corrigendum
- Corrigendum to: Validation of a pneumatic tube system to transport surgical pathology biopsy samples
- Letters to the Editor
- A transnational collaborative network dedicated to the study and applications of the vascular endothelial growth factor-A in medical practice: the VEGF Consortium
- Detection and a functional characterization of the novel FBN1 intronic mutation underlying Marfan syndrome: case presentation
- Effect of haemolysis on the determination of CCL17/thymus and activation-regulated chemokine (TARC) and CCL22/macrophage-derived chemokine (MDC)
- Evaluation of long-term stability of cannabinoids in standardized preparations of cannabis flowering tops and cannabis oil by ultra-high-performance liquid chromatography tandem mass spectrometry
- Impact of citrated blood collection tubes on red cell morphology: implications for the measurement of plasma glucose
- Validation of a pneumatic tube system to transport surgical pathology biopsy samples
- Antioxidant capacity in patients with type 2 diabetes: a preliminary investigation on gender-specific differences in an Italian population
Articles in the same Issue
- Frontmatter
- Editorial
- Visual assessment of sample quality: quo usque tandem?
- Reviews
- Machine learning in laboratory medicine: waiting for the flood?
- Is irisin the new player in exercise-induced adaptations or not? A 2017 update
- Opinion Paper
- Can a combination of average of normals and “real time” External Quality Assurance replace Internal Quality Control?
- Genetics and Molecular Diagnostics
- The UGT1A1*28 gene variant predicts long-term mortality in patients undergoing coronary angiography
- General Clinical Chemistry and Laboratory Medicine
- Laboratory performance of sweat conductivity for the screening of cystic fibrosis
- Making sense of a haemolysis monitoring and reporting system: a nationwide longitudinal multimethod study of 68 Australian laboratory participant organisations
- Visual assessment of hemolysis affects patient safety
- Strong impact on plasma protein profiles by precentrifugation delay but not by repeated freeze-thaw cycles, as analyzed using multiplex proximity extension assays
- Validation of the Six Sigma Z-score for the quality assessment of clinical laboratory timeliness
- Proficiency testing program for hemoglobin E, A2 and F analysis in Thailand using lyophilized hemoglobin control materials
- Application of κ free light chains in cerebrospinal fluid as a biomarker in multiple sclerosis diagnosis: development of a diagnosis algorithm
- Antiphosphatidylserine/prothrombin antibodies (aPS/PT) as potential diagnostic markers and risk predictors of venous thrombosis and obstetric complications in antiphospholipid syndrome
- An evaluation of the SENTiFIT 270 analyser for quantitation of faecal haemoglobin in the investigation of patients with suspected colorectal cancer
- Evaluation of the Aptima HBV Quant assay vs. the COBAS TaqMan HBV test using the high pure system for the quantitation of HBV DNA in plasma and serum samples
- Reference Values and Biological Variations
- Reference intervals for stone risk factors in 24-h urine among healthy adults of the Han population in China
- Cardiovascular Diseases
- Rule-out of non-ST elevation myocardial infarction by five point of care cardiac troponin assays according to the 0 h/3 h algorithm of the European Society of Cardiology
- Infectious Diseases
- Diagnostic and prognostic value of presepsin vs. established biomarkers in critically ill patients with sepsis or systemic inflammatory response syndrome
- Association of adrenal hormone metabolites and mortality over a 6-year follow-up in COPD patients with acute exacerbation
- Corrigendum
- Corrigendum to: Validation of a pneumatic tube system to transport surgical pathology biopsy samples
- Letters to the Editor
- A transnational collaborative network dedicated to the study and applications of the vascular endothelial growth factor-A in medical practice: the VEGF Consortium
- Detection and a functional characterization of the novel FBN1 intronic mutation underlying Marfan syndrome: case presentation
- Effect of haemolysis on the determination of CCL17/thymus and activation-regulated chemokine (TARC) and CCL22/macrophage-derived chemokine (MDC)
- Evaluation of long-term stability of cannabinoids in standardized preparations of cannabis flowering tops and cannabis oil by ultra-high-performance liquid chromatography tandem mass spectrometry
- Impact of citrated blood collection tubes on red cell morphology: implications for the measurement of plasma glucose
- Validation of a pneumatic tube system to transport surgical pathology biopsy samples
- Antioxidant capacity in patients with type 2 diabetes: a preliminary investigation on gender-specific differences in an Italian population
